Available Technologies

Details

Project TitleTargeted Drug Delivery Platform for Myocardial Infarction and Post-MI Cardiac Regeneration
Track CodeP42980
Websitewww.lvg.virginia.edu
Short Description

Principal Investigator:

Kimberly Kelly, Ph.D.

Abstract

Dr. Kelly at the University of Virginia has developed novel liposomal vehicles to deliver small molecules specifically to damaged cardiac tissues, which could lead to more effective targeted treatments for myocardial infarction (MI) and post-MI cardiac regeneration. Their strategy has been demonstrated proof-of-concept in vivo

 
TagsMyocardial Infarction, Post-MI Regeneration, targeted delivery
 
Posted DateJun 28, 2017 3:03 PM

Files

File Name Description
Targeted Drug Delivery Platform for Myocardial Infarction and Post-MI Cardiac Regeneration None Download
WO2016205397A2 None Download
Dasa et al 2015 J Control Release, 220, 556-67 None Download